Location History:
- Abington, GB (2004)
- Cambridge, GB (2011 - 2017)
Company Filing History:
4 out of 38 
2 out of 259 
1 out of 1,168 
Years Active: 2004-2017
Title: Armin Sepp: Innovator in Pulmonary Disease Treatment
Introduction
Armin Sepp is a distinguished inventor based in Cambridge, GB, known for his significant contributions to the field of pulmonary disease treatment. With a total of seven patents to his name, he has developed innovative methods and formulations aimed at improving therapeutic outcomes for patients suffering from respiratory conditions.
Latest Patents
Among his latest patents, Sepp has disclosed methods for targeting pulmonary diseases using agents that bind to specific targets in pulmonary tissue. This includes the use of agents such as antibody fragments and antagonists for the manufacture of long-acting formulations designed for local delivery to pulmonary tissue. His work also encompasses methods for administering these agents to produce prolonged therapeutic effects in the lungs. Additionally, he has explored the use of antagonists of TNFR1 for creating formulations aimed at treating or preventing lung inflammation and respiratory diseases. His inventions also include stable anti-TNFR1 polypeptides and antibody variable domains, which are crucial for treating inflammatory diseases like arthritis and COPD.
Career Highlights
Sepp has worked with notable organizations such as Domantis Limited and the Medical Research Council, where he has honed his expertise in the development of therapeutic agents. His career is marked by a commitment to advancing medical science and improving patient care through innovative solutions.
Collaborations
Throughout his career, Armin Sepp has collaborated with esteemed colleagues, including Andrew David Griffiths and Rudolf M T De Wildt. These partnerships have contributed to the success of his research and the development of his patented technologies.
Conclusion
Armin Sepp's work in the field of pulmonary disease treatment exemplifies the impact of innovation in healthcare. His patents and collaborations reflect a dedication to improving therapeutic options for patients, showcasing the importance of continued research and development in this vital area of medicine.